ADH-6 TFA
Product Specifications
Target
MDM-2/p53|||Apoptosis|||Others
Related Pathways
Others|||Apoptosis
Bioactivity
ADH-6 TFA, a tripyridylamide compound, effectively disrupts the self-assembly of the aggregation-nucleating subdomain of mutant p53 DBD, thereby targeting and disassociating mutant p53 aggregates in human cancer cells. This action restores the transcriptional activity of p53, resulting in cell cycle arrest and apoptosis. Consequently, ADH-6 TFA holds potential for cancer research [1].
Molecular Formula
C31H37F3N8O11
Molecular Weight
754.67
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
